St. Louis, MO, United States of America

John McPherson


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1998-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: John McPherson: Pioneering Innovations in Muscle Disease Research

Introduction

John McPherson, an innovative inventor from St. Louis, MO, has made significant contributions to the field of muscular dystrophy research. With two patents to his name, his work focuses on the identification and treatment of genetic mutations linked to autosomal recessive limb-girdle muscular dystrophy.

Latest Patents

McPherson's latest patents include groundbreaking technologies related to 𝛿-sarcoglycan antibodies and nucleic acid sequences. His research presents a substantially pure nucleic acid sequence encoding a 35 kDa non-dystrophin component (𝛿-sarcoglycan) of the dystrophin-glycoprotein complex. The resulting peptides, when used to immunize mammals, stimulate the production of antibodies that specifically bind to 𝛿-sarcoglycan.

Furthermore, McPherson's patents disclose methods for identifying mutations in the 𝛿-sarcoglycan gene, which are associated with autosomal recessive limb-girdle muscular dystrophy. This identification is instrumental in designing nucleic acid probes that can specifically target mutant forms of 𝛿-sarcoglycan. Such advancements not only enhance diagnostic capabilities through direct DNA sequencing techniques but also pave the way for targeted therapeutic strategies.

Career Highlights

Throughout his career, John McPherson has collaborated with various institutions and researchers, contributing to advancements in genetic research. He has been associated with reputable companies, including Washington University, where his work has furthered the understanding of muscular dystrophies.

Collaborations

McPherson has had the opportunity to collaborate with notable coworkers such as Kevin P. Campbell and Daniel Yonil Jung. These partnerships have enriched his research and fostered a collaborative environment focused on tackling challenging scientific problems in genetic disorders.

Conclusion

John McPherson stands as a significant figure in the realm of muscle disease research, with his patents representing a vital step forward in the diagnosis and potential treatment of autosomal recessive limb-girdle muscular dystrophy. His dedication to innovation and collaboration continues to make a meaningful impact on the scientific community and the lives of those affected by muscular dystrophies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…